Check out this call for abstracts for the Data to Drugs and Diagnostics (D2D) conference taking place June 11-12, 2014.

Since its introduction in 2011, Bio-Rad Laboratory’s Droplet Digital PCR (ddPCR™) technology has demonstrated the potential to be a transformative technology, particularly in clinical applications. At the second annual CHI Digital PCR Conference in San Diego, CA, Oct. 7–9, 2013, 12 scientists using Bio-Rad’s Droplet Digital PCR systems will highlight ddPCR applications that have advanced their research.

Innovations will lead to better treatment, assessment for children

The function of molecular diagnostics is to analyze the composition of a patient’s genetic makeup in order to reveal any potential predispositions of that individual to specific diseases. Identifying these biomarkers can allow treatment options to be outlined that are likely to be effective in particular patients and not in others.